Studies on orally active cephalosporin esters. VI. Synthesis and antimicrobial activity of 3-(3-isoxazolyl)oxymethylcephalosporin derivatives. 1990

E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
Sankyo Research Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

The synthesis and biological activities of a series of 3-(isoxazol-3-yl)oxymethyl cephalosporins are described. 7-[2-(2-Aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]-3- [(isoxazol-3-yl)oxymethyl]-3-cephem-4-carboxylic acid (7a) showed potent activity against both Gram-positive and Gram-negative bacteria including some beta-lactamase producing species. Its pivaloyloxymethyl ester provided a good urinary recovery after oral administration to mice.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
March 1987, The Journal of antibiotics,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
July 1990, Chemical & pharmaceutical bulletin,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
May 1990, The Journal of antibiotics,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
December 1989, Chemical & pharmaceutical bulletin,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
September 1989, Chemical & pharmaceutical bulletin,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
September 1989, Chemical & pharmaceutical bulletin,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
August 1990, The Journal of antibiotics,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
January 1988, Journal of medicinal chemistry,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
December 1985, The Journal of antibiotics,
E Nakayama, and K Watanabe, and M Miyauchi, and K Fujimoto, and J Ide
September 2022, Acta chimica Slovenica,
Copied contents to your clipboard!